Loading stock data...

Concord Biotech Limited

NSE: CONCORDBIO BSE: CONCORDBIO

NSE
1,655.00 16.00 (0.98%)

Prev Close

1639

Open Price

1642

Volume

230,774

Today Low / High

1631.4 / 1680

52 WK Low / High

1345 / 2664

Range

1,572 - 1,738

BSE
1,651.80 16.90 (1.03%)

Prev Close

1634.9

Open Price

1638

Volume

1,570

Today Low / High

1631.4 / 1676.75

52 WK Low / High

1370.05 / 2658

Range

1,569 - 1,734

The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 1655 (target range: 1,572 - 1,738), reflecting a change of 16 (0.97621%). On the BSE, it is listed at 1651.8 (target range: 1,569 - 1,734), showing a change of 16.9 (1.0337%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.

15 Sep 1,642.00 0.83%
12 Sep 1,654.00 -0.91%
11 Sep 1,679.90 -2.45%
10 Sep 1,605.00 4.06%
09 Sep 1,615.00 -2.02%
08 Sep 1,670.00 -3.54%
05 Sep 1,662.30 -0.28%
04 Sep 1,700.10 -1.85%
03 Sep 1,675.00 1.43%
02 Sep 1,714.00 -1.48%
01 Sep 1,675.00 0.65%
29 Aug 1,694.00 -0.73%
28 Aug 1,700.50 -0.28%
26 Aug 1,718.60 -0.73%
25 Aug 1,767.60 -2.77%
22 Aug 1,750.00 1.01%
21 Aug 1,715.00 2.05%

Concord Biotech Limited Graph

Concord Biotech Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Concord Biotech Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 1,655.00, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 1,651.80 1,668.32 1,501.49 - 1,835.15
1,684.84 1,347.87 - 2,021.80
1,701.35 1,190.95 - 2,211.76
Bearish Scenario 1,651.80 1,635.28 1,471.75 - 1,798.81
1,618.76 1,295.01 - 1,942.52
1,602.25 1,121.57 - 2,082.92

Overview of Concord Biotech Limited

ISIN

INE338H01029

Industry

Biotechnology

Vol.Avg

160,049

Market Cap

173,202,580,720

Last Dividend

10.7

Official Website

Visit Website

IPO Date

2023-08-18

DCF Diff

1,315.79

DCF

323

Financial Ratios Every Investor Needs

Stock Dividend of CONCORDBIO

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2025-09-03 September 03, 25 10.7 10.7 2025-09-03 2025-10-09
2024-06-21 June 21, 24 8.75 8.75 2024-06-22 2024-07-29

Stock Rating Details for CONCORDBIO

Metric Value Recommendation
Overall Rating C- Strong Sell
DCF Score 3 Neutral
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 1,200.09 Cr 611.05 Cr 589.04 Cr 0.4908 0.00 Cr 0.00 Cr 451.96 Cr 371.64 Cr 35.54 550.78 Cr 0.3097
2024-03-31 998.06 Cr 244.78 Cr 753.27 Cr 0.7547 22.90 Cr 11.13 Cr 626.19 Cr 308.10 Cr 29.45 465.91 Cr 0.3087
2023-03-31 853.17 Cr 180.21 Cr 672.96 Cr 0.7888 32.83 Cr 10.50 Cr 326.52 Cr 240.09 Cr 22.95 383.22 Cr 0.2814
2022-03-31 708.44 Cr 177.92 Cr 530.52 Cr 0.7489 29.09 Cr 10.58 Cr 243.96 Cr 174.93 Cr 16.72 297.34 Cr 0.2469
2021-03-31 604.05 Cr 120.33 Cr 483.73 Cr 0.8008 0.00 Cr 7.09 Cr 306.89 Cr 234.89 Cr 22.45 341.74 Cr 0.3889

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 1.18 Cr 2,034.25 Cr 221.53 Cr 1,812.7175 Cr 2.97 Cr 1.79 Cr 239.67 Cr 844.22 Cr 0.00 Cr 0.00 Cr 39.29 Cr 184.0626 Cr
2024-03-31 15.14 Cr 1,700.71 Cr 174.06 Cr 1,526.6455 Cr 9.74 Cr -5.40 Cr 207.95 Cr 786.48 Cr 3.66 Cr 0.00 Cr -263.36 Cr 142.1554 Cr
2023-03-31 3.50 Cr 1,513.98 Cr 223.98 Cr 1,290.0010 Cr 31.55 Cr 28.05 Cr 212.32 Cr 765.48 Cr 0.00 Cr 0.00 Cr -168.12 Cr 191.8460 Cr
2022-03-31 0.67 Cr 1,312.80 Cr 209.57 Cr 1,103.2230 Cr 62.49 Cr 61.83 Cr 195.12 Cr 643.56 Cr 0.00 Cr 0.00 Cr -160.85 Cr 155.1680 Cr
2021-03-31 5.14 Cr 1,182.55 Cr 183.17 Cr 999.3730 Cr 89.28 Cr 84.14 Cr 153.61 Cr 557.75 Cr 0.00 Cr 0.00 Cr -195.70 Cr 105.7390 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 247.4104 Cr -162.9811 Cr -98.6669 Cr 136.2382 Cr -19.6343 Cr 1.1831 Cr -111.1722 Cr 371.6423 Cr -5.8487 Cr -91.5392 Cr -31.7134 Cr
2024-03-31 265.4671 Cr -154.6093 Cr -99.2149 Cr 179.7786 Cr 11.6429 Cr 15.1421 Cr -85.6885 Cr 308.1032 Cr -26.5036 Cr -71.4529 Cr 4.3609 Cr
2023-03-31 246.0018 Cr -157.9501 Cr -85.2194 Cr 100.9170 Cr 2.8323 Cr 3.4992 Cr -145.0848 Cr 322.0134 Cr -26.5961 Cr -53.5635 Cr -17.2273 Cr
2022-03-31 207.4750 Cr -111.7880 Cr -100.1640 Cr 51.9700 Cr -4.4770 Cr 0.6670 Cr -155.5050 Cr 237.5180 Cr -26.6557 Cr -70.5210 Cr -41.5090 Cr
2021-03-31 166.8170 Cr -195.2050 Cr 31.1240 Cr -37.3590 Cr 2.7360 Cr 5.1440 Cr -204.1760 Cr 312.7200 Cr 38.3210 Cr -5.7060 Cr -42.3770 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-06-30 203.99 Cr 45.10 Cr 158.88 Cr 0.7789 43.62 Cr 44.06 Cr 4.21 76.57 Cr 0.2160
2025-03-31 429.88 Cr 211.42 Cr 218.47 Cr 0.5082 175.81 Cr 140.39 Cr 13.42 199.81 Cr 0.3266
2024-12-31 244.22 Cr 52.40 Cr 191.82 Cr 0.7854 84.69 Cr 75.92 Cr 7.26 114.51 Cr 0.3109
2024-09-30 310.18 Cr 76.32 Cr 233.86 Cr 0.7540 123.36 Cr 95.74 Cr 9.15 143.75 Cr 0.3087
2024-06-30 215.80 Cr 48.30 Cr 167.50 Cr 0.7762 135.84 Cr 59.59 Cr 5.70 91.59 Cr 0.2761

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 1.18 Cr 316.54 Cr 317.73 Cr 521.65 Cr 239.67 Cr 1,135.24 Cr 844.22 Cr 2,034.25 Cr 221.53 Cr
2024-12-31 0.00 Cr 0.00 Cr 283.74 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -1,590.38 Cr
2024-09-30 7.40 Cr 275.28 Cr 318.29 Cr 344.45 Cr 250.42 Cr 934.65 Cr 806.03 Cr 1,764.34 Cr 173.97 Cr
2024-06-30 -281.67 Cr 563.33 Cr 281.67 Cr 0.00 Cr 0.00 Cr 281.67 Cr 0.00 Cr 0.00 Cr -1,526.65 Cr
2024-03-31 15.14 Cr 295.03 Cr 310.18 Cr 369.04 Cr 207.95 Cr 896.23 Cr 786.48 Cr 1,700.71 Cr 174.06 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2024-12-31 75.92 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 95.74 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 59.59 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 95.02 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-12-31 77.57 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Biotechnology

Company Name Symbol Price Market Cap Volume
Biocon Limited BIOCON ₹357.85 ₹478,431,136,000.00 ₹1,275,698.00
Piramal Pharma Limited PPLPHARMA ₹204.39 ₹271,685,039,598.00 ₹3,479,504.00
Syngene International Limited SYNGENE ₹671.35 ₹269,456,321,587.00 ₹784,923.00
Concord Biotech Limited CONCORDBIO ₹1,655.00 ₹173,139,811,000.00 ₹227,475.00
Blue Jet Healthcare Limited BLUEJET ₹716.90 ₹124,357,359,598.00 ₹670,289.00
Jubilant Ingrevia Limited JUBLINGREA ₹705.90 ₹112,436,457,900.00 ₹110,242.00
Supriya Lifescience Limited SUPRIYA ₹643.55 ₹51,794,705,940.00 ₹81,432.00
Zota Health Care Limited ZOTA ₹1,496.40 ₹45,052,713,360.00 ₹46,124.00
Dishman Carbogen Amcis Limited DCAL ₹268.65 ₹42,119,752,950.00 ₹109,411.00

Key Executives

Vice President of Sales & Marketing and Head of Limbasi Plant-3
Mr. Devang Bhatt

Gender: male

Year Born:

General Manager, International Business Development
Sundeep Bengani

Gender: Not Specified

Year Born:

Chairman & MD
Mr. Sudhir Jairam Vaid

Gender: male

Year Born: 1952

Chief Financial Officer
Mr. Lalit Sethi

Gender: male

Year Born:

Vice President of Formulation Division & Head of Valthera Unit-2
Mr. Manoj Kumar

Gender: male

Year Born:

Company Secretary, Compliance Officer & Assistant Vice President of Finance
Mr. Prakash Lalchand Sajnani

Gender: male

Year Born:

Joint MD, Chief Executive Officer & Director
Mr. Ankur Vaid

Gender: male

Year Born: 1982

FAQs about Concord Biotech Limited

Who is the CEO of the company?

The CEO is Ankur Vaid.

What is the current market price of the stock?

The current price is ₹1,655.60.

What is the 52-week price range?

The range is ₹1345-2664.

What is the market capitalization of the company?

The market capitalization is ₹17,320.26 crores.

What is the dividend yield?

The dividend yield is 0.65%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 48.65.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Concord Biotech Limited (ISIN: INE338H01029) is a leading Biotechnology in India. With a market capitalization of ₹17,320.26 crores and an average daily volume of 160,049 shares, it operates in the Biotechnology. The company last declared a dividend of ₹10.7.